Articles on cancer

Recently published by URMC faculty

 

March 2009

“Patient Anxiety About Prostate Cancer Independently Predicts Early Initiation of Androgen Deprivation Therapy for Biochemical Cancer Recurrence in Older Men: A Prospective Cohort Study.” Dale W, Hemmerich J, Bylow K, Mohile S, Mullaney M, Stadler WM. J Clin Oncol. 2009 Mar 2. [Epub ahead of print]

“New insights into cancer-associated thrombosis.” Sousou T, Khorana AA. Arterioscler Thromb Vasc Biol. 2009 Mar;29(3):316-20.

February 2009

“Patterns and Timing of Initial Relapse in Patients Subsequently Undergoing Transplantation for Hodgkin's Lymphoma.” Dhakal S, Biswas T, Liesveld JL, Friedberg JW, Phillips GL, Constine LS. Int J Radiat Oncol Biol Phys. 2009 Feb 26. [Epub ahead of print]

“Stereotactic Body Radiotherapy for Treatment of Adrenal Metastases.” Chawla S, Chen Y, Katz AW, Muhs AG, Philip A, Okunieff P, Milano MT. Int J Radiat Oncol Biol Phys. 2009 Feb 26. [Epub ahead of print]

“Novel nonclassical MHC class Ib genes associated with CD8 T cell development and thymic tumors.” Goyos A, Ohta Y, Guselnikov S, Robert J. Mol Immunol. 2009 Feb 21. [Epub ahead of print]

“Inhibition of intracranial glioma growth by endometrial regenerative cells.” Han X, Meng X, Yin Z, Rogers A, Zhong J, Rillema P, Jackson JA, Ichim TE, Minev B, Carrier E, Patel AN, Murphy MP, Min WP, Riordan NH. Cell Cycle. 2009 Feb 30;8(4). [Epub ahead of print]

“Rituximab immunotherapy results in the induction of a lymphoma idiotype-specific T-cell response in patients with follicular lymphoma: support for a "vaccinal effect" of rituximab.” Hilchey SP, Hyrien O, Mosmann TR, Livingstone AM, Friedberg JW, Young F, Fisher RI, Kelleher RJ Jr, Bankert RB, Bernstein SH. Blood. 2009 Feb 4. [Epub ahead of print]

“Follicular Lymphoma in the United States: First Report of the National LymphoCare Study.” Friedberg JW, Taylor MD, Cerhan JR, Flowers CR, Dillon H, Farber CM, Rogers ES, Hainsworth JD, Wong EK, Vose JM, Zelenetz AD, Link BK. J Clin Oncol. 2009 Feb 9. [Epub ahead of print]

“Urothelial Carcinoma Versus Squamous Cell Carcinoma of Bladder: Is Survival Different With Stage Adjustment?” Scosyrev E, Yao J, Messing E. Urology. 2009 Feb 2. [Epub ahead of print]

“Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer.” Palapattu GS, Wu C, Silvers CR, Martin HB, Williams K, Salamone L, Bushnell T, Huang LS, Yang Q, Huang J. Prostate. 2009 Feb 2. [Epub ahead of print]

“In vitro and In vivo Anticancer Effects of the Novel Vitamin E Ether Analogue RRR-{alpha}-Tocopheryloxybutyl Sulfonic Acid in Prostate Cancer.” Ni J, Mai T, Pang ST, Haque I, Huang K, Dimaggio MA, Xie S, James NS, Kasi D, Chemler SR, Yeh S. Clin Cancer Res. 2009 Feb 1;15(3):898-906.

“Enhanced ovarian cancer tumorigenesis and metastasis by the macrophage colony-stimulating factor.” Toy EP, Azodi M, Folk NL, Zito CM, Zeiss CJ, Chambers SK. Neoplasia. 2009 Feb;11(2):136-44.

January 2009

“Different panels of markers should be used to predict mammary Paget's disease associated with in situ or invasive ductal carcinoma of the breast.” Lester T, Wang J, Bourne P, Yang Q, Fu L, Tang P. Ann Clin Lab Sci. 2009 Winter;39(1):17-24.

“Controversies in the diagnosis and management of childhood acute immune thrombocytopenic purpura.” Segel GB, Feig SA. Pediatr Blood Cancer. 2009 Jan 22. [Epub ahead of print]

“Diagnostic criteria to distinguish hypocellular acute myeloid leukemia from hypocellular myelodysplastic syndromes and aplastic anemia: recommendations for a standardized approach.” Bennett JM, Orazi A. Haematologica. 2009 Jan 14. [Epub ahead of print]

“Differences in the Status of Involved Lymph Nodes and the Direction of Metastatic Lymphatic Flow from Tumors into Involved Nodes Between Submucosal and T2-4 Thoracic Squamous Cell Esophageal Cancers.” Peters JH. World J Surg. 2009 Jan 10. [Epub ahead of print]

“Identifying cancer patients at risk for venous thromboembolism.” Sousou T, Khorana A. Hamostaseologie. 2009;29(1):121-124.

“Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies:IPD-based meta-analysis of cohort studies.” Kanda J, Ichinohe T, Matsuo K, Benjamin RJ, Klumpp TR, Rozman P, Blumberg N, Mehta J, Sohn SK, Uchiyama T. Transfusion. 2009 Jan 2. [Epub ahead of print]

“RRR-{alpha}-Vitamin E Succinate Potentiates the Antitumor Effect of Calcitriol in Prostate Cancer without Overt Side Effects.” Yin Y, Ni J, Chen M, Guo Y, Yeh S. Clin Cancer Res. 2009 Jan 1;15(1):190-200.

December 2008

“Use of the Rad51 promoter for targeted anti-cancer therapy.” Hine CM, Seluanov A, Gorbunova V. Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20810-5. Epub 2008 Dec 23.

“Sex and racial differences in bladder cancer presentation and mortality in the US.” Scosyrev E, Noyes K, Feng C, Messing E. Cancer. 2008 Dec 15; [Epub ahead of print]

“Natural History of CNS Relapse in Patients With Aggressive Non-Hodgkin's Lymphoma: A 20-Year Follow-Up Analysis of SWOG 8516--The Southwest Oncology Group.” Bernstein SH, Unger JM, Leblanc M, Friedberg J, Miller TP, Fisher RI. J Clin Oncol. 2008 Dec 1; [Epub ahead of print]

“Androgen deprivation therapy for advanced prostate cancer: why does it fail and can its effects be prolonged?” Singer EA, Golijanin DJ, Messing EM. Can J Urol. 2008 Dec;15(6):4381-7.

“Can we finally target the leukemic stem cells?” Jordan CT. Best Pract Res Clin Haematol. 2008 Dec;21(4):615-20.

“Modern surgery for esophageal cancer.” Dubecz A, Molena D, Peters JH. Gastroenterol Clin North Am. 2008 Dec;37(4):965-87.

“Management of prostate cancer in the older man.” Mohile SG, Lachs M, Dale W. Semin Oncol. 2008 Dec;35(6):597-617.

November 2008

“Increased STAT-3 and synchronous activation of Raf-1-MEK-1-MAPK, andphosphatidylinositol 3-Kinase-Akt-mTOR pathways in atypical and anaplastic meningiomas.” Johnson MD, O'Connell M, Vito F, Bakos RS. J Neurooncol. 2008 Nov 26; [Epub ahead of print]

“Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer.” Khorana AA, Francis CW, Blumberg N, Culakova E, Refaai MA, Lyman GH. Arch Intern Med. 2008 Nov 24;168(21):2377-81.

“Peroxisome proliferator-activated receptor gamma overexpression and knockdown: impact on human B cell lymphoma proliferation and survival.” Garcia-Bates TM, Peslak SA, Baglole CJ, Maggirwar SB, Bernstein SH, Phipps RP. Cancer Immunol Immunother. 2008 Nov 19; [Epub ahead of print]

“Plexin C1, A Receptor for Semaphorin 7A, Inactivates Cofilin and Is a Potential Tumor Suppressor for Melanoma Progression.” Scott GA, McClelland LA, Fricke AF, Fender A. J Invest Dermatol. 2008 Nov 6. [Epub ahead of print]

“Tissue elasticity properties as biomarkers for prostate cancer.” Hoyt K, Castaneda B, Zhang M, Nigwekar P, di Sant'agnese PA, Joseph JV, Strang J,Rubens DJ, Parker KJ. Cancer Biomark. 2008;4(4-5):213-25.

“Maximizing immune responses: the effects of covalent peptide linkage to beta-2-microglobulin.” Bauer SM, Williams MA, Howell AP, Schwarz E, Smith ES, Zauderer M. Oncol Res. 2008;17(5):205-16.

October 2008

“Vagal regulation, cortisol, and sleep disruption in women with metastatic breast cancer.” Palesh O, Zeitzer JM, Conrad A, Giese-Davis J, Mustian KM, Popek V, Nga K, Spiegel D. J Clin Sleep Med. 2008 Oct 15;4(5):441-9.

“Peroxisome Proliferator-Activated Receptor {gamma} Overexpression Suppresses Growth and Induces Apoptosis in Human Multiple Myeloma Cells.” Garcia-Bates TM, Bernstein SH, Phipps RP. Clin Cancer Res. 2008 Oct 15;14(20):6414-6425.

“Canonical and non-canonical JAK-STAT signaling.” Li WX. Trends Cell Biol. 2008 Oct 8. [Epub ahead of print]

September 2008

“Incidence of de novo cancer and lymphoproliferative disorders after liver transplantation in relation to age and duration of follow-up.” Jain A, Patil VP, Fung J. Liver Transpl. 2008 Sep 29;14(10):1406-1411 [Epub ahead of print]

“Treatment of Mice with the Ah Receptor Agonist and Human Carcinogen Dioxin Results in Altered Numbers and Function of Hematopoietic Stem Cells.” Singh KP, Wyman A, Casado FL, Garrett R, Gasiewicz TA. Carcinogenesis. 2008 Sep 26; [Epub ahead of print]

“Comparison of Referring and Final Pathology for Patients With Non-Hodgkin's Lymphoma in the National Comprehensive Cancer Network.” Lacasce AS, Kho ME, Friedberg JW, Niland JC, Abel GA, Rodriguez MA, Czuczman MS, Millenson MM, Zelenetz AD, Weeks JC. J Clin Oncol. 2008 Sep 2; [Epub ahead of print]

“Association of seedling myomas with myometrial hyperplasia.” Cramer SF, Mann L, Calianese E, Daley J, Williamson K. Hum Pathol. 2008 Sep 15; [Epub ahead of print]

“Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer.” Khorana AA, Francis CW, Menzies KE, Wang JG, Hyrien O, Hathcock J, Mackman N, Taubman MB. J Thromb Haemost. 2008 Sep 15. [Epub ahead of print]

“Prostate-specific antigen levels in relation to consumption of nonsteroidal anti-inflammatory drugs and acetaminophen: results from the 2001-2002 National Health and Nutrition Examination Survey.” Singer EA, Palapattu GS, van Wijngaarden E. Cancer. 2008 Sep 8. [Epub ahead of print]

“Hematopoietic niche and bone meet.” Frisch, Benjamin J. Porter, Rebecca L. Calvi, Laura M. Current Opinion in Supportive & Palliative Care. 2(3):211-7, 2008 Sep.

August 2008

“Photodynamic dose does not correlate with long-term tumor response to mTHPC-PDT performed at several drug-light intervals.” Wang KK, Mitra S, Foster TH. Med Phys. 2008 Aug;35(8):3518-26.

“Targeting cyclooxygenase-2 in hematological malignancies: rationale and promise.” Bernard, M P. Bancos, S. Sime, P J. Phipps, R P. Current Pharmaceutical Design. 14(21):2051-60, 2008.

July 2008

“Soft tissue sarcoma in the setting of chronic cutaneous graft versus host disease after allogenic bone marrow transplantation.” Bylund, Kevin C.  Giampoli, Ellen.  Singh, Deepinder.  Doerr, Timothy. Sahasrabudhe, Deepak.  Liesveld, Jane.  Constine, Louis S. Cancer Investigation.  26(6):638-41, 2008 Jul.

“Five tumors over six years in eighth decade of life.” Corbin, Kimberly.  Fisher, Susan.  Sahasrabudhe, Deepak.  Pandya, Kishan. Brasacchio, Ralph.  Constine, Louis S.Cancer Investigation.  26(6):634-7, 2008 Jul.

“Rapid method for detection of mutations in the nucleophosmin gene in acute myeloid leukemia.” Laughlin, Todd S.  Becker, Michael W.  Liesveld, Jane L.  Mulford, Deborah A.  Abboud, Camille N.  Brown, Patrick.  Rothberg, Paul G. Journal of Molecular Diagnostics. 10(4):338-45, 2008 Jul.

“Multispectral imaging of hematopoietic cells: Where flow meets morphology.” McGrath, Kathleen E.  Bushnell, Timothy P.  Palis, James. Journal of Immunological Methods.  336(2):91-7, 2008 Jul 31.

“Irradiance-Genetic risk factors of suicidal behaviour acid-photodynamic therapy of superficial basal cell carcinomas.” Cottrell, William J. Paquette, Anne D. Keymel, Kenneth R. Foster, Thomas H. Oseroff, Allan R. Clinical Cancer Research. 14(14):4475-83, 2008 Jul 15.

“hSMG-1 and ATM sequentially and independently regulate the G1 checkpoint during oxidative stress.” Gehen, S C.  Staversky, R J.  Bambara, R A.  Keng, P C.  O'Reilly, M A. Oncogene.  27(29):4065-74, 2008 Jul 3.

“Reply to frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients.” Khorana, Alok A.  Francis, Charles W.  Lyman, Gary H. Cancer. 113(1):224, 2008 Jul 1.

June 2008

“Is There an Entity of Chemically Induced BCR-ABL-Positive Chronic Myelogenous Leukemia?” Lichtman, Marshall A. Oncologist.  13(6):645-54, 2008 Jun.

“Impact of the more restrictive definition of atypical squamous cells introduced by the 2001 Bethesda System on the sensitivity and specificity of the Papanicolaou test: a 5-year follow-up study of Papanicolaou tests originally interpreted as ASCUS, reclassified according to Bethesda 2001 criteria.” Thrall, Michael J.  Pambuccian, Stefan E.  Stelow, Edward B.  McKeon, Dan M.  Miller, Lizette.  Savik, Kay.  Gulbahce, H Evin. Cancer.  114(3):171-9, 2008 Jun 25.

May 2008

“Monitoring Pc 4 photodynamic therapy in clinical trials of cutaneous T-cell lymphoma using noninvasive spectroscopy.” Lee, Tammy K.  Baron, Elma D.  Foster, Thomas H. Journal of Biomedical Optics.  13(3):030507, 2008 May-Jun.

“Supportive-expressive group therapy for primary breast cancer patients: A randomized prospective multicenter trial.” Classen, Catherine C;  Kraemer, Helena C;  Blasey, Christine; Giese-Davis, Janine;  Koopman, Cheryl;  Gronskaya Palesh, Oxana; Atkinson, Ami;  DiMiceli, Sue;  Stonisch-Riggs, Gail;  Westendorp, Joan; Morrow, Gary R;  Spiegel, David. Psycho-Oncology. Vol 17(5) May 2008, 438-447.

Nov. 2007

“Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma.” Connolly, Gregory C.  Chen, Rui.  Hyrien, Ollivier.  Mantry, Parvez. Bozorgzadeh, Adel.  Abt, Peter.  Khorana, Alok A. Thrombosis Research.  122(3):299-306, 2008.